Walleye Trading
NVCR icon

Walleye Trading’s NovoCure NVCR Stock Holding History

Walleye Trading’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,000
Closed -$89.4K – 4524
2024
Q4 		$89.4K Buy
+3,000
New +$63.5K ﹤0.01% 3589
2024
Q1 		– Sell
-4,700
Closed -$70.2K – 5152
2023
Q4 		$70.2K Buy
4,700
+2,500
+114% +$33.5K ﹤0.01% 4259
2023
Q3 		$35.5K Buy
+2,200
New +$63.4K ﹤0.01% 4287
2023
Q2 		– Sell
-66,200
Closed -$3.98M – 5036
2023
Q1 		$3.98M Buy
66,200
+58,900
+807% +$4.71M 0.01% 1202
2022
Q4 		$535K Sell
7,300
-5,000
-41% -$376K ﹤0.01% 2754
2022
Q3 		$935K Buy
12,300
+3,900
+46% +$304K ﹤0.01% 2299
2022
Q2 		$584K Sell
8,400
-11,000
-57% -$829K ﹤0.01% 2745
2022
Q1 		$1.61M Buy
19,400
+700
+4% +$51.6K 0.01% 1847
2021
Q4 		$1.4M Sell
18,700
-4,100
-18% -$412K ﹤0.01% 1936
2021
Q3 		$2.65M Buy
22,800
+16,200
+245% +$2.45M 0.01% 1382
2021
Q2 		$1.46M Buy
6,600
+6,000
+1,000% +$1.17M 0.01% 1785
2021
Q1 		$79K Sell
600
-47,800
-99% -$7.56M ﹤0.01% 4191
2020
Q4 		$8.38M Sell
48,400
-48,400
-50% -$6.62M 0.04% 470
2020
Q3 		$10.8M Buy
96,800
+87,400
+930% +$6.99M 0.06% 259
2020
Q2 		$557K Buy
9,400
+2,500
+36% +$164K ﹤0.01% 2195
2020
Q1 		$465K Buy
6,900
+2,900
+73% +$229K ﹤0.01% 1927
2019
Q4 		$337K Sell
4,000
-1,800
-31% -$145K ﹤0.01% 2722
2019
Q3 		$434K Sell
5,800
-10,100
-64% -$808K ﹤0.01% 2281
2019
Q2 		$1M Buy
15,900
+9,600
+152% +$486K 0.01% 1594
2019
Q1 		$303K Sell
6,300
-10,400
-62% -$501K ﹤0.01% 2691
2018
Q4 		$559K Sell
16,700
-9,900
-37% -$362K ﹤0.01% 2368
2018
Q3 		$1.39M Buy
26,600
+25,400
+2,117% +$1.01M 0.01% 1724
2018
Q2 		$38K Sell
1,200
-11,700
-91% -$325K ﹤0.01% 4303
2018
Q1 		$281K Buy
12,900
+4,200
+48% +$90.3K ﹤0.01% 3185
2017
Q4 		$175 Buy
+8,700
New +$168K ﹤0.01% 3543

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Walleye Trading's NVCR Position: Q1 2026 in Review

Walleye Trading sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 25,808 shares — an estimated $334K sold.

Walleye Trading first reported a position in NVCR in Q4 2018 and held it in 14 quarters. The position peaked at $2.04M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Walleye Trading reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 25,808 NovoCure shares in Q1 2026, an estimated $334K.
  • Walleye Trading first reported a position in NovoCure in Q4 2018 and held it in 14 quarters.
  • Walleye Trading's NovoCure position peaked at $2.04M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.